Study: Postoperative potassium risk overstated for cardiac bypass patients
Editor's Note The common practice of administering potassium after bypass surgery can be safely abandoned in patients with normal blood levels, according to results of the randomized TIGHT-K trial. According to a September 3 report in Medscape, potassium supplementation is a widely accepted means of reducing the risk of postoperative…
Study: Secondary conditions go unaddressed in female heart surgery patients
Editor's Note Female patients undergoing heart surgery are less likely than male patients to have concomitant procedures—that is, having additional ailments addressed during cardiac procedures—despite guidelines recommending such treatments, according to two studies led by Michigan Medicine. News-Medical.Net reported the news June 28. The first study, involving over 5,000 patients…
Heart disease trial supports less-invasive alternative to SAVR, CABG surgery
Editor's Note Contrary to previous findings, less-invasive percutaneous intervention combining fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) with transcatheter aortic valve replacement (TAVR) could be a viable alternative to surgery for patients with severe aortic stenosis (AS) and concomitant obstructive coronary artery disease (CAD). That’s according to the results…
FDA warns of continued cardiac pump safety concerns after series of recalls
Editor's Note The US Food and Drug Administration (FDA) is urging healthcare providers to avoid using Getinge heart devices due to continued safety concerns that remain unaddressed despite previous recalls. Issued to healthcare providers May 8, the warning letter applies to Getinge/Maquet/Datascope Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pump (IABP) devices…
LivaNova receives FDA 510(k) approval for new in-line blood monitor
Editor's Note The Essenz™ In-Line Blood Monitor (ILBM) has received U.S. FDA 510(k) clearance and CE mark, as announced by manufacturer LivaNova on August 30. The new ILBM provides “accurate and continuous measurement of essential blood parameters for perfusionists throughout cardiopulmonary bypass procedures,” and integrates with the company’s Essenz Perfusion…
FDA: Class I recall of LivaNova’s LifeSPARC System
Editor's Note The Food and Drug Administration (FDA) on September 30 identified the recall by LivaNova (TandemLife) of its LifeSPARC System, Model LS-1000, as Class I, the most serious. The recall was initiated because of the risk of unintentional extended pump stop during Controller Critical Failure mode, caused by a…
Free Daily News
- Study: Education, exercise improve knee OA with or without prior surgery
- Study: Early surgery outperforms endoscopy for long-term pancreatitis
- Study: Blood thinner, NSAID combination raises bleeding risk
- Hospital financial report predicts stability, high cybersecurity costs for 2025
- IV fluid shortage drives innovation in hospital hydration practices
- FDA Class 1 recalls target anesthesia workstations, ambulatory infusion pumps, ventilators
- Five leadership lessons from an ASC CEO
- CMS final rule for CY 2025: Key updates impacting Medicare payments, quality programs
- GAO urges HHS to strengthen cybersecurity oversight
- Study: GLP-1s reduce TKA complications for non-diabetic patients with obesity